News

AddToAny

Google+ Facebook Twitter Twitter

New leukaemia treatment for children

The NHS will be able to offer children a new cancer therapy labelled the “most exciting treatment advance for decades”.

CAR-T is for aggressive leukaemia and can be used when other drugs have failed. It typically costs hundreds of thousands of pounds per patient.

NHS England boss Simon Stevens says a fair and affordable price has been reached with manufacturer Novartis.

Hospitals could start giving it to a small number of children within weeks. The first three NHS hospitals to apply to use the CAR-T (which stands for “chimeric antigen receptor T-cell”) therapy are in London, Manchester and Newcastle.

The CAR-T treatment from Novartis has a list price of £282,000 per patient, though the actual figure NHS England will pay for it has not been disclosed.

The funding will come from the Cancer Drugs Fund, which aims to fast-track access to the most promising new cancer treatments.

 

Image credit | Science Photo Library 

Related Articles

Blood clot discovery

Scientists have discovered new ways in which the body regulates blood clots, which could lead to the development of better treatments to help prevent and treat conditions including heart diseases, stroke and vascular dementia.

Under the microscope: Takotsubo cardiomyopathy

Under the microscope This month: Takotsubo cardiomyopathy

Detecting atrial fibrillation

Could routine screening for atrial fibrillation be in the pipeline? Jonathan Mant is leading the programme that he hopes will be the catalyst.

Salt Getty

Recognising pseudohypernatraemia

Biochemistry lead Dan Kelly looks at sodium citrate contamination and how to identify the condition.

Top